18010362_digital_payerv3-01.png

The Digital Payer: Fact or Fiction?

Our experts, Sue O’Leary, Senior Vice President Prime Access, Jenny Blackham, Vice President Client Partnerships and Head of Digital Solutions Michelle Collins recently led a webinar with the team at NetworkPharma and MedComms Networking. Discussing ‘the digital payer – fact or fiction?’ the webinar was a brilliant platform to discuss perspectives and share ideas about about evolving payer communications in the changing digital landscape.

read more >>
Prime GlobalThe Digital Payer: Fact or Fiction?
18010359-Omics-future-of-PM-social-v7a_FacebookLinkedInTwitter.png

Overcoming the challenges of gene therapy

Once considered science fiction, a number of different gene therapy approaches are now being adopted in clinical practice to target a range of diseases. Our Prime Omics team discuss ‘overcoming the challenges of gene therapy’ in their whitepaper. Read the full piece below.
read more >>

Prime GlobalOvercoming the challenges of gene therapy
18010362_Evidence_or_Opinion_TL_v1-002_Page_2.png

Evidence or Opinion: what is really driving decisions following accelerated approvals?

Delivery of confirmatory studies following any accelerated approval has been an area of growth and contention. Sue O’Leary, Senior Vice President of Prime Access, and Jenny Blackham, Vice President of Client Partnerships, take a closer look at what is happening.

read more >>
Prime GlobalEvidence or Opinion: what is really driving decisions following accelerated approvals?